Zai Lab Ltd (NAS:ZLAB)
$ 17.92 -1.14 (-5.98%) Market Cap: 1.79 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 2.43 GF Score: 69/100

Zai Lab Ltd at Goldman Sachs Global Healthcare Conference Transcript

Jun 16, 2022 / 04:20PM GMT
Release Date Price: $23.14 (-5.59%)
Ziyi Chen
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Great. Thank you for joining this session with Zai Lab. This is China healthcare analyst Ziyi Chen. And today's session is with Zai Lab CFO, Billy Cho. Thank you for joining.

Questions & Answers

Ziyi Chen
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Billy, let's get started with the Shanghai lockdown. So how that has been impacting your operations? Is everyone back to the office yet?

Ki Chul Cho
Zai Lab Limited - CFO

Yes. Thanks, Ziyi, and good morning, everyone. Yes, pretty much since June 1, so a little over 2 weeks now, everyone is back in the office and functioning normally. As some of you may be seeing in media, what they did was -- Shanghai to be specific -- really increased the testing capacity so that if there's any super-spreader events, they can quickly mobilize and -- so you may see an increase in the cadence of testing. But that's going to result in, hopefully, no more systematic lockdowns.

So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot